Evidence map›Paper›PMID 26862899›Full record

ArticlePloS one2016

GABA and Endocannabinoids Mediate Depotentiation of Schaffer Collateral Synapses Induced by Stimulation of Temperoammonic Inputs.

Yukitoshi Izumi, Charles F Zorumski

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Temperoammonic Stimulation Depotentiates Schaffer Collateral LTP via p38 MAPK Downstream of Adenosine A1 Receptors.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  4. Cannabinoids in Parkinson's Disease.Cannabis and cannabinoid research · 2017
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Yukitoshi IzumiDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States of America.
Charles F ZorumskiDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States of America.
Taylor Family Institute for Innovative Psychiatric ResearchWashington University in St. Louis · US

Funding

MODULATION OF HIPPOCAMPAL SYNAPTIC PLASTICITYR01MH077791 · NIMH · WASHINGTON UNIVERSITY · PI ZORUMSKI, CHARLES F · 2007 to 2013
$2.4M
Oxysterols and NMDAR FunctionR01MH101874 · NIMH · WASHINGTON UNIVERSITY · PI MENNERICK, STEVEN J, ZORUMSKI, CHARLES F · 2014 to 2018
$1.9M
ETHANOL, NEUROSTEROIDS & HIPPOCAMPAL PLASTICITYR01AA017413 · NIAAA · WASHINGTON UNIVERSITY · PI ZORUMSKI, CHARLES F · 2009 to 2013
$1.8M
NIAAA NIH HHS AA017413NIAAA NIH HHS R01 AA017413NIMH NIH HHS MH077791NIMH NIH HHS MH10184NIMH NIH HHS R01 MH077791NIMH NIH HHS R01 MH101874
6 · The paper itself

Abstract

Long-term potentiation (LTP) of Schaffer collateral (SC) synapses in the hippocampus is thought to play a key role in episodic memory formation. Because the hippocampus is a shorter-term, limited capacity storage system, repeated bouts of learning and synaptic plasticity require that SC synapses reset to baseline at some point following LTP. We previously showed that repeated low frequency activation of temperoammonic (TA) inputs to the CA1 region depotentiates SC LTP without persistently altering basal transmission. This heterosynaptic depotentiation involves adenosine A1 receptors but not N-methyl-D-aspartate receptors, metabotropic glutamate receptors or L-type calcium channels. In the present study, we used rat hippocampal slices to explore other messengers contributing to TA-induced SC depotentiation, and provide evidence for the involvement of cannabinoid-1 and γ-aminobutyric acid (GABA) type-A receptors as more proximal signaling events leading to synaptic resetting, with A1 receptor activation serving as a downstream event. Surprisingly, we found that TA-induced SC depotentiation is independent of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate glutamate receptors. We also examined the involvement of mitogen-activated protein kinases (MAPKs), and found a role for extracellular-signal related kinase 1/2 and p38 MAPK, but not c-Jun-N-terminal kinase. These results indicate that low frequency stimulation of TA inputs to CA1 activates a complex signaling network that instructs SC synaptic resetting. The involvement of GABA and endocannabinoids suggest mechanisms that could contribute to cognitive dysfunction associated with substance abuse and neuropsychiatric disorders.

Indexed as

Long-Term PotentiationAnimalsBrainCA1 Region, HippocampalCalcium Channels, L-TypeCognition DisordersEndocannabinoidsgamma-Aminobutyric AcidHippocampusKainic Acid ReceptorsLong-Term Synaptic DepressionMAP Kinase Signaling Systemp38 Mitogen-Activated Protein KinasesRatsReceptors, AMPAReceptors, GlutamateCalcium Channels, L-TypeEndocannabinoidsgamma-Aminobutyric AcidKainic Acid Receptorsp38 Mitogen-Activated Protein KinasesReceptors, AMPAReceptors, GlutamateReceptors, N-Methyl-D-Aspartate

Identifiers

PMID26862899
PMCPMC4749331
OpenAlexW2268699309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.